TZU-10802-02040
3 vaccinations
2 coded responses
24 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 925 / CA
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-05
Registered in v-safe
-
2021-04-05
Dose 1 — Pfizer-BioNTech
-
2021-04-05
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain, Swelling · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-07
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
-
2021-04-27
Dose 2 — Pfizer-BioNTech
- 2021-04-27
-
2021-04-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-30
- 2021-05-01
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-03
- 2021-05-04
-
2021-05-21
Survey response — day 21, dose 2MedDRA: Anxiety, Decreased appetite, Diarrhoea, Dizziness, Fatigue, Heart rate increased, Hypoaesthesia oral, Nausea, Neutrophil count increased, Paraesthesia, Respiratory rate increased, White blood cell count increased — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Anxiety attacks (adrenaline rush, tingling hands and feet, numb tongue, heart rate and breathing accelerated, nausea, diarrhea, dizziness, fatigue, low appetite) and mildly elevated WBC and neutrophil countsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-25
- 2021-06-01
- 2021-06-08
- 2021-07-27
- 2021-10-26
-
2021-11-05
Dose 3 — Pfizer-BioNTech
- 2022-04-27
-
2022-05-06
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Morning sickness from pregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-11-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Pfizer-BioNTech | |
| 2 | 2021-04-27 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
Free text
Release 8 — day 21, dose 2
Symptoms: Anxiety attacks (adrenaline rush, tingling hands and feet, numb tongue, heart rate and breathing accelerated, nausea, diarrhea, dizziness, fatigue, low appetite) and mildly elevated WBC and neutrophil counts
Release 11 — 6 months, dose 3
Symptoms: Morning sickness from pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | ✓ | ✓ | ✓ |
| SD | Decreased appetite | ✓ | ✓ | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Hypoaesthesia oral | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Neutrophil count increased | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory rate increased | ✓ | ✓ | ✓ |
| SD | White blood cell count increased | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release